Skip to main content

Table 2 Demographic characteristics, treatment, and visual outcomes of patients with birdshot chorioretinopathy

From: Visual response and anatomical changes on sequential spectral-domain optical coherence tomography in birdshot chorioretinopathy treated with local corticosteroid therapy

Patient

Onset presentation

Prior treatment

VA initial

VA final

Disease course OD

Disease course OS

Family history

HLA A29

Treatment

1

54 yo

None

20/50 OD

20/50 OD

VC, ERM, RD, CME, PCL

VC, ERM, CME, PCL, CNVb

No

Positive

Focal laser OS, pneumatic retinopexy OD, IVK × 711 OD, IVK × 9 OS

54 yo

20/30 OS

20/30 OS

2

48 yo

None

20/30 OD

20/50 OD

ERM, CME, PCL, glaucomac

ERM, PCL

Yes

Positive

Subtenon triamcinolone acetate OD, DC secondary to glaucoma

48 yo

20/20 OS

20/30 OS

3

34 yo

Systemic immuno-suppressantsa

20/70 OD

20/40 OD

ERM, CME, PCL

ERM, CME, PCL

Yes

Positive

IVK × 4 OD, IVK × 5 OS

40 yo

20/60 OS

20/200 OS

4

26 yo

None

20/40 OD

20/40 OD

VC, PVD, PCL

VC, PVD, CME, PCL

No

Positive

IVK × 1 OD, IVK × 2 OS

54 yo

20/200 OS

20/70 OS

  1. PCL pale choroidal lesions, ERM epiretinal membrane, RD retinal detachement, CME cystoid macular edema, CNV choroidal neovascularization, VC vitreous cell, C/D cup to disk, IVK intravitreal triamcinolone acetate, PRP pan-retinal photocoagulation, N/A not applicable, PVD posterior vitreous detachment
  2. aCyclosporine, extrafoveal, non-compliant to glaucoma medication